182 related articles for article (PubMed ID: 11323508)
21. Role of the DPC4 tumor suppressor gene in adenocarcinoma of the ampulla of Vater: analysis of 140 cases.
McCarthy DM; Hruban RH; Argani P; Howe JR; Conlon KC; Brennan MF; Zahurak M; Wilentz RE; Cameron JL; Yeo CJ; Kern SE; Klimstra DS
Mod Pathol; 2003 Mar; 16(3):272-8. PubMed ID: 12640108
[TBL] [Abstract][Full Text] [Related]
22. [SMAD4/DPC4 (small mothers against decapentaplegic deleted in pancreatic carcinoma, locus 4). Tumor suppressor gene].
Bull Cancer; 1998 Oct; 85(10):832. PubMed ID: 9867367
[No Abstract] [Full Text] [Related]
23. A novel histone deacetylase inhibitor identified by high-throughput transcriptional screening of a compound library.
Su GH; Sohn TA; Ryu B; Kern SE
Cancer Res; 2000 Jun; 60(12):3137-42. PubMed ID: 10866300
[TBL] [Abstract][Full Text] [Related]
24. Cancer gets Mad: DPC4 and other TGFbeta pathway genes in human cancer.
Moskaluk CA; Kern SE
Biochim Biophys Acta; 1996 Dec; 1288(3):M31-3. PubMed ID: 9011179
[No Abstract] [Full Text] [Related]
25. Characterization of a newly established human pancreatic carcinoma cell line, UK Pan-1.
Fralix KD; Ahmed MM; Mattingly C; Swiderski C; McGrath PC; Venkatasubbarao K; Kamada N; Mohiuddin M; Strodel WE; Freeman JW
Cancer; 2000 May; 88(9):2010-21. PubMed ID: 10813711
[TBL] [Abstract][Full Text] [Related]
26. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1.
Hahn SA; Schutte M; Hoque AT; Moskaluk CA; da Costa LT; Rozenblum E; Weinstein CL; Fischer A; Yeo CJ; Hruban RH; Kern SE
Science; 1996 Jan; 271(5247):350-3. PubMed ID: 8553070
[TBL] [Abstract][Full Text] [Related]
27. A clinically relevant model of human pancreatic adenocarcinoma identifies patterns of metastasis associated with alterations of the TGF-beta/Smad4 signaling pathway.
Holloway S; Davis M; Jaber R; Fleming J
Int J Gastrointest Cancer; 2003; 33(1):61-9. PubMed ID: 12909738
[TBL] [Abstract][Full Text] [Related]
28. SCF(beta-TrCP1) controls Smad4 protein stability in pancreatic cancer cells.
Wan M; Huang J; Jhala NC; Tytler EM; Yang L; Vickers SM; Tang Y; Lu C; Wang N; Cao X
Am J Pathol; 2005 May; 166(5):1379-92. PubMed ID: 15855639
[TBL] [Abstract][Full Text] [Related]
29. Homozygous deletions inactivate DCC, but not MADH4/DPC4/SMAD4, in a subset of pancreatic and biliary cancers.
Hilgers W; Song JJ; Haye M; Hruban RR; Kern SE; Fearon ER
Genes Chromosomes Cancer; 2000 Apr; 27(4):353-7. PubMed ID: 10719364
[TBL] [Abstract][Full Text] [Related]
30. Effect of deleted pancreatic cancer locus 4 gene transfection on biological behaviors of human colorectal carcinoma cells.
Xiao DS; Wen JF; Li JH; Hu ZL; Zheng H; Fu CY
World J Gastroenterol; 2005 Jan; 11(3):348-52. PubMed ID: 15637742
[TBL] [Abstract][Full Text] [Related]
31. Genetic alterations of the transforming growth factor beta receptor genes in pancreatic and biliary adenocarcinomas.
Goggins M; Shekher M; Turnacioglu K; Yeo CJ; Hruban RH; Kern SE
Cancer Res; 1998 Dec; 58(23):5329-32. PubMed ID: 9850059
[TBL] [Abstract][Full Text] [Related]
32. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.
Poncelet AC; de Caestecker MP; Schnaper HW
Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488
[TBL] [Abstract][Full Text] [Related]
33. Loss of DPC4 expression and its correlation with clinicopathological parameters in pancreatic carcinoma.
Hua Z; Zhang YC; Hu XM; Jia ZG
World J Gastroenterol; 2003 Dec; 9(12):2764-7. PubMed ID: 14669329
[TBL] [Abstract][Full Text] [Related]
34. [The effects of transferring DPC4-adenovirus on pancreatic adenocarcinoma cells].
Feng XL; Zhang ZD; Tian L; Wei YQ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Sep; 35(5):607-11. PubMed ID: 15460398
[TBL] [Abstract][Full Text] [Related]
35. Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression.
Wilentz RE; Iacobuzio-Donahue CA; Argani P; McCarthy DM; Parsons JL; Yeo CJ; Kern SE; Hruban RH
Cancer Res; 2000 Apr; 60(7):2002-6. PubMed ID: 10766191
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of p21(WAF1/CIP1) is an early event in the development of pancreatic intraepithelial neoplasia.
Biankin AV; Kench JG; Morey AL; Lee CS; Biankin SA; Head DR; Hugh TB; Henshall SM; Sutherland RL
Cancer Res; 2001 Dec; 61(24):8830-7. PubMed ID: 11751405
[TBL] [Abstract][Full Text] [Related]
37. Dpc4 protein in mucinous cystic neoplasms of the pancreas: frequent loss of expression in invasive carcinomas suggests a role in genetic progression.
Iacobuzio-Donahue CA; Wilentz RE; Argani P; Yeo CJ; Cameron JL; Kern SE; Hruban RH
Am J Surg Pathol; 2000 Nov; 24(11):1544-8. PubMed ID: 11075857
[TBL] [Abstract][Full Text] [Related]
38. Inactivation of both alleles of the DPC4/SMAD4 gene in advanced colorectal cancers: identification of seven novel somatic mutations in tumors from Japanese patients.
Koyama M; Ito M; Nagai H; Emi M; Moriyama Y
Mutat Res; 1999 Aug; 406(2-4):71-7. PubMed ID: 10479724
[TBL] [Abstract][Full Text] [Related]
39. Identification of an agent selectively targeting DPC4 (deleted in pancreatic cancer locus 4)-deficient pancreatic cancer cells.
Wang H; Han H; Von Hoff DD
Cancer Res; 2006 Oct; 66(19):9722-30. PubMed ID: 17018631
[TBL] [Abstract][Full Text] [Related]
40. DPC4/Smad4 expression and outcome in pancreatic ductal adenocarcinoma.
Biankin AV; Morey AL; Lee CS; Kench JG; Biankin SA; Hook HC; Head DR; Hugh TB; Sutherland RL; Henshall SM
J Clin Oncol; 2002 Dec; 20(23):4531-42. PubMed ID: 12454109
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
